No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

a long-acting FGF21 analogue in phase 2, and early-stage candidates partnered with Dicerna and UBE. Novo Nordisk follows a number of other companies into the category, notably Roche which has ...